Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN24233750) titled 'Evaluating the effect of automated insulin pumps on pain levels in people with diabetes-related nerve damage' on March 2.
Study Type: Interventional
Study Design:
Two-centre randomized cross-over feasibility study (Treatment)
Primary Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Condition:
Type 1 diabetes
Nutritional, Metabolic, Endocrine
Intervention:
PAINLESS is a two-centre randomized cross-over feasibility study with blinded outcome assessment of patients with painful diabetic neuropathy (defined as pain severity of =4 on an 11-point numerical rating scale [NRS] measuring 24-hour pain scor...